Innovent Biologics, Inc. (HKG:1801)
Hong Kong
· Delayed Price · Currency is HKD 84.90
+2.30 (2.78%)
Apr 29, 2026, 4:08 PM HKT
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of 143.33 billion as of April 29, 2026. Its market cap has increased by 74.45% in one year.
Market Cap
143.33B
Enterprise Value
126.17B
Revenue
14.51B
Ranking
n/a
PE Ratio
157.93
Stock Price
84.90
Market Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 18.54B to 143.33B, an increase of 673.11%. That is a compound annual growth rate of 31.37%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| WuXi Biologics | 137.71B |
| Akeso | 121.22B |
| Sichuan Kelun-Biotech Biopharmaceutical | 115.34B |
| Sino Biopharmaceutical | 101.49B |
| BeOne Medicines AG | 261.35B |
| RemeGen | 76.50B |
| 3SBio | 56.85B |
| Biocytogen Pharmaceuticals (Beijing) | 46.28B |